Publications by authors named "Milagrosa Montes Ros"

The coronavirus disease 2019 (COVID-19) pandemic has affected the world radically since 2020. Spain was one of the European countries with the highest incidence during the first wave. As a part of a consortium to monitor and study the evolution of the epidemic, we sequenced 2,170 samples, diagnosed mostly before lockdown measures.

View Article and Find Full Text PDF

Background: Antibiotic resistance is the main cause for Helicobacter pylori therapy failure. Frequently, empirical regimens have been recommended in patients with various H. pylori eradication failures.

View Article and Find Full Text PDF

Anti-N-methyl-D-aspartate receptor encephalitis is a neuroimmunologic disorder that has been increasingly diagnosed during the past 5 years. It provokes a predictable syndrome treated with several immunomodulatory agents, such as corticosteroids and/or biologics. We managed a child with this disease who developed Pneumocystis jirovecii pneumonia as a direct infectious complication of the use of rituximab.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Milagrosa Montes Ros"

  • - Milagrosa Montes Ros's research primarily focuses on infectious diseases, with significant contributions to understanding the dynamics of the COVID-19 pandemic in Spain, particularly regarding the genetic variants that influenced its spread during the initial wave.
  • - Her work highlights the issue of antibiotic resistance in Helicobacter pylori, detailing a five-year study that links rising resistance rates to the effectiveness of eradication therapies in northern Spain.
  • - Ros has also explored the complications arising from neuroimmunological disorders, specifically analyzing a case of Pneumocystis jirovecii pneumonia in a child with postherpetic encephalitis treated with immunomodulatory therapies.